Retour aux projets

14438.1;7 PFLS-LS

Profiling of Synthetic Virus-like Nanoparticle Pneumococcal Vaccine Candidates

Résumé

Profiling of Synthetic Virus-like Nanoparticle Pneumococcal Vaccine Candidates

Textes supplémentaires

Abstract

Virometix AG is developing a broad-spectrum pneumococcal vaccine based on its synthetic virus-like particle (SVLP) technology, comprising surface proteins (virulence factors) that are commonly expressed by all pneumococcal serotypes. The vaccine should overcome major shortcomings of the current capsular polysaccharide-based vaccines including limited serotype coverage and high manufacturing complexity. This KTI project should support preclinical profiling of Virometix vaccine candidates in animal models of pneumococcal diseases.

Participants

John A. Robinson

Kontaktperson

robinson@oci.uzh.ch

Universität Zürich Organisch-chemisches Institut John A. Robinson Winterthurerstr. 190 8057 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2012-08-31
Date de fin
2014-09-08
Coûts totaux approuvés
CHF 400000.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%